Thromboembolism Trials in Berlin, Germany
Conditions / Thromboembolism / Berlin, Germany
Thromboembolism is a medical condition with active clinical research programs worldwide.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00839826 | ODiXahip - a Phase IIa Dose Escalating Proof of Principle Trial | COMPLETED | PHASE2 |
| NCT02913326 | A Clinical Trial Comparing Efficacy and Safety of Dabigatran Etexilate With Warfarin in Patients With Cerebral Venous and Dural Sinus Thrombosis (RE-SPECT CVT) | COMPLETED | PHASE3 |
| NCT00847301 | Pradaxa (Dabigatran Etexilate) 150 mg/q.d. in Patients With Moderate Renal Impairment After Hip or Knee Replacement Surgery | COMPLETED | — |
| NCT00846807 | Pradaxa (Dabigatran Etexilate 220 mg/q.d. in the General Population After Hip or Knee Replacement Surgery | COMPLETED | — |
| NCT00353678 | Factor Xa Inhibitor YM150 for the Prevention of Blood Clot Formation in Veins After Scheduled Hip Replacement (ONYX-2) | COMPLETED | PHASE2 |
| NCT02579122 | REVIparin-BRIDging-in a General Practice Setting in GErmany | TERMINATED | — |
| NCT02064439 | Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism) | COMPLETED | PHASE3 |
| NCT00986154 | Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study). | COMPLETED | PHASE3 |
| NCT01004939 | Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous Thromboembolism | COMPLETED | — |
| NCT02447081 | Amplatzer™Amulet™ Post-Market Study (Amulet™PMS) | COMPLETED | — |